# Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption

> **NCT05232942** · — · UNKNOWN · sponsor: **Hospital Clínico Universitario de Valladolid** · enrollment: 200 (estimated)

## Conditions studied

- Migraine
- Headache, Migraine

## Interventions

- **OTHER:** Headache calendar completion

## Key facts

- **NCT ID:** NCT05232942
- **Lead sponsor:** Hospital Clínico Universitario de Valladolid
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-15
- **Primary completion:** 2024-02-15
- **Final completion:** 2024-08-15
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05232942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05232942, "Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05232942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*